Severe constipation as the first clinical manifestation in multiple endocrine neoplasia type 2B: a case report and literature review

Abstract

Background: The occurrence of multiple endocrine neoplasia type 2B (MEN2B) in Asians is very rare. In particular, patients with intractable constipation as the main clinical manifestation are even rarer. Atypical clinical manifestations are likely to lead to a diagnostic delay. In this report, we described a case of a delayed diagnosis of MEN2B, and the first clinical manifestation was intractable constipation. Case presentation: A female teenager had suffered from intractable constipation since infancy. Because the colonoscopy and biopsy results from local hospitals did not confirm the presence of congenital megacolon, the girl had been followed up at a local clinic for a long time. The diagnosis was not confirmed until thyroid masses were found in the Pediatric Department of Shanghai Ruijin Hospital when she was 12 years old. According to our detailed evaluation, she suffered from Hirschsprung disease (HD), growth retardation, medullary thyroid carcinoma (MTC) and mucosal neuroma due to a mutation in the RET gene. Thus, the diagnosis of MEN2B was confirmed. Afterward, the girl underwent several surgeries and was still being followed up before the article was published. Conclusion: MEN2B has atypical clinical symptoms in the early stage. Refractory constipation may be the only clinical manifestation that lasts for several years. Therefore, we recommend that early screening and gene sequencing should be performed for patients with severe constipation due to HD to determine the cause of the disease and to improve the survival outcome.

Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology

“…Mild disease in children was also reported by many studies 15 , 38 . Contributing factors may include lower maturity and function of ACE2 receptors 39 and viral co-infection that leads to limited replication of SARS-CoV-2 in the respiratory tract 40 . Interestingly, clade GV showed the highest prevalence among children compared to other age groups.…”

A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States

“…Over 4.2 million children in the United States have tested positive for coronavirus disease-2019 (COVID-19) since the onset of the pandemic 1 , 2 . In comparison with adults, preliminary reports suggest that children (< 18 years of age) have relatively lower odds of adverse clinical outcomes associated with COVID-19 3 – 8 . The lower observed prevalence of COVID-19 in the pediatric age-group worldwide is partially attributed to widespread school closures in response to the pandemic 7 , 9 , 10 .…”

Lebensrettende Maßnahmen bei Kindern (Paediatric Life Support, PLS)

“…Eine ausführliche Diskussion über COVID-19 bei Kindern würde den Rahmen der aktuellen Leitlinien sprengen. Im Allgemeinen weisen Kinder eine mildere Erkrankung auf und sind für andere möglicherweise weniger ansteckend als Erwachsene [ 8 – 10 ]. Dies kann jedoch in Einzelfällen oder bei anderen Viren in Zukunft anders sein [ 11 – 13 ].…”